• Profile
Close

Dexmedetomidine infusion as an analgesic adjuvant during laparoscopic cholecystectomy: A randomized controlled study

BMC Anesthesiology Apr 26, 2018

Bielka K, et al. - Researchers assessed the efficacy and safety of dexmedetomidine (DEX) infusion in adult patients (18–79 years), with American Society of Anesthesiology (ASA) physical status I–II, undergoing elective laparoscopic cholecystectomy (LC) and randomly assigned to 0.5 μg/kg/h DEX infusion from induction of anaesthesia to extubation or normal saline infusion. Both during and after elective LC, improved analgesia was achieved with intraoperative DEX infusion, which was noted to be safe and effective as an analgesic. With DEX, a significant attenuation in the number of patients with severe postoperative pain, postoperative morphine consumption and prolonged time to first use of rescue analgesia was achieved.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay